(Q45061083)

9 December 2017

Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide (English)

1 reference

9 December 2017

0 references

Luís Villela

3

0 references

Francesc Bosch

object named as

Francesc Bosch

series ordinal

2

0 references

Laura Rosiñol

series ordinal

4

object named as

Laura Rosiñol

1 reference

9 December 2017

Clara Montagut

1

1 reference

PubMed ID

15370232

9 December 2017

Joan Bladé

series ordinal

5

1 reference

9 December 2017

1 August 2004

1 reference

9 December 2017

1 reference

9 December 2017

45

1 reference

9 December 2017

8

1 reference

9 December 2017

1711-1712

1 reference

Thalidomide in refractory and relapsing multiple myeloma

9 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

Deep venous thrombosis and thalidomide therapy for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

Nephrotoxic potential of Bence Jones proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

Tobramycin nephrotoxicity. A prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

Renal Failure in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638841

10.1080/10428190310001638841

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

15370232